Home » Topics » Regulatory » Patents

Patents
RSS

Conjugates of HMG-CoA reductase and renin inhibitors in development at LEK

Sep. 8, 2009

Taiho presents retinoid RARalpha receptor agonists as antitumor agents

Sep. 7, 2009

Sanwa describes thyroid hormone receptor ligands for the treatment of hyperlipidemia

Sep. 7, 2009

Enanta identifies novel hepatitis C virus NS3 NS4A protease inhibitors

Sep. 7, 2009

GSK claims AMPA glutamate receptor ligands for psychotic disorders

Sep. 7, 2009

Calcium channel blockers claimed by Cosunter as antihypertensives

Sep. 4, 2009

Alla Chem presents 5-HT6 receptor antagonists for the treatment of cognition disorders

Sep. 4, 2009

Roche claims c-Met inhibitors for the treatment of cancer and other conditions

Sep. 4, 2009

Novel angiotensin II antagonists described by Merck & Co. as antihypertensives

Sep. 4, 2009

Beta-secretase inhibitors for the treatment of Alzheimer's disease disclosed by Boehringer Ingelheim

Sep. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.